A comprehensive view of AGC Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
AGC Biologics Strengthens Executive Leadership with Appointment of Dr. Christoph Winterhalter as Chief Business Officer
Published:
March 25, 2024
by News Direct
|
AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset Metachromatic Leukodystrophy, Orchard Therapeutics’ Lenmeldy™ (atidarsagene autotemcel)
Published:
March 19, 2024
by News Direct
|
FDA Approves First Gene Therapy for Pediatric MLD from Orchard Therapeutics, and AGC Biologics Tapped to Manufacture It
Published:
March 19, 2024
by Biopharm International
|
AGC Biologics to build new facility in Japan.
Published:
January 11, 2024
by PBR, Pharmaceutical Business Review (CBNB Abstracts)
|
AGC Biologics to build new manufacturing site in Japan
Published:
January 08, 2024
by Outsourcing-Pharma.com
|
Ask us about our Health Care Sector market view